Targeted disruption of cd39/diphosphohydrolase results in disordered hemostasis and thromboregulation - Enjyoji, K; Sevigny, J; Lin, Y; Frenette, PS; Christie, PD; Esch II, JS; Imai, M; Edelberg, JM; Rayburn, H; Lech, M; Beeler, DL; Csizmadia, E; Wagner, DD; Robson, SC; Rosenberg, RD (Nat Med, 1999)